Work

Supplemental Figure S2 from A Novel Pharmacologic Activity of Ketorolac for Therapeutic Benefit in Ovarian Cancer Patients

Year: 2023

Type: supplementary-materials

Abstract: Supplemental Figure S2. Purified Ovarian Tumor Cells Express EpCam and MUC16/CA125.

DOI: 10.1158/1078-0432.22456119

Authors: Yuna Guo, S. Ray Kenney, Linda Cook, Sarah F. Adams, Teresa Rutledge, Elsa Romero, Tudor I. Oprea, Larry A. Sklar, Edward Bedrick, Charles L. Wiggins, Huining Kang, Lesley Lomo, Carolyn Y. Muller, Angela Wandinger-Ness, Laurie G. Hudson

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361884296

Cites:

Cited by:

Related to: 10